BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 3987836)

  • 21. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of CFU-GM response to piperazinedione versus cyclophosphamide in normal mice.
    OKunewick JP; Buffo MJ; Kociban DL
    Exp Hematol; 1984 Jun; 12(5):297-300. PubMed ID: 6547096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preventive effect of TJ-48 on recovery from radiation injury].
    Ohnishi Y; Yasumizu R; Ikehara S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1494-9. PubMed ID: 2658831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The enhancement of committed hematopoietic stem cell colony formation by nandrolone decanoate after sublethal whole body irradiation.
    Gallicchio VS; Chen MG; Watts TD
    Int J Cell Cloning; 1984 Nov; 2(6):383-93. PubMed ID: 6394658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mast cell growth factor enhances multilineage hematopoietic recovery in vivo following radiation-induced aplasia.
    Patchen ML; Fischer R; Schmauder-Chock EA; Williams DE
    Exp Hematol; 1994 Jan; 22(1):31-9. PubMed ID: 7506673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
    Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
    Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
    Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
    Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
    Chow FP; Zsebo K; Hamburger AW
    Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
    Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
    Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.
    Lin H; She YH; Cassileth BR; Sirotnak F; Cunningham Rundles S
    Int Immunopharmacol; 2004 Jan; 4(1):91-9. PubMed ID: 14975363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late effects of chemotherapy on hematopoietic progenitor cells.
    Fried W; Adler S
    Exp Hematol; 1985; 13 Suppl 16():49-56. PubMed ID: 3886419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
    Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
    Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
    Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
    Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic factors influencing murine hematopoietic productivity in culture.
    Phillips RL; Couzens MS; Van Zant G
    J Cell Physiol; 1995 Jul; 164(1):99-107. PubMed ID: 7790403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE
    Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.